[{"Assets_0_Q2_USD":105267000.0,"CommonStockSharesOutstanding_0_Q2_shares":19132645.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-14412000.0,"NetIncomeLoss_1_Q2_USD":-8718000.0,"NetIncomeLoss_2_Q2_USD":-16360000.0,"StockholdersEquity_0_Q2_USD":94603000.0,"Ticker":"KZR","CIK":"1645666","name":"KEZAR LIFE SCIENCES, INC.","OfficialName":"Kezar Life Sciences Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"829139908.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]